- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01319071
Genetic Polymorphism and Israeli Top-level Athletes
March 17, 2011 updated by: Hillel Yaffe Medical Center
It is still unknown whether different genetic elements play a role in athletes' ability to create their area of specificity.In a study conducted in our laboratory few years ago, we genotyped 22 genes in 2 athletic groups (endurance and sprinters) and in age and gender matched nonathletic controls.
Few of these genes were found to be associated with athletic performance and area of specificity.
Since then a few more genes have been found that are related to athletic performance, and our aim in the current study is to expand our research to these new genes which include 3 genetic cascades: genes associated with body fluid balance and homeostasis, genes associated with muscle strength, and genes associated with bioenergy.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Netanya, Israel
- Wingate Institute
-
Contact:
- Sigal Ben Zaken, PhD
- Phone Number: 972-52-2209853
-
Principal Investigator:
- Sigal Ben Zaken, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 40 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Athletes training at the Wingate Institute
Description
Inclusion Criteria:
- Top-level athletes
- Other athletes
Exclusion Criteria:
- All others
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Control group
|
Extraction of blood sample from top-level athletes
|
Top-level athletes
|
Extraction of blood sample from top-level athletes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Identification of genes related to top-level athletes
Time Frame: Four months
|
Four months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (Anticipated)
December 1, 2011
Study Completion (Anticipated)
December 1, 2012
Study Registration Dates
First Submitted
March 17, 2011
First Submitted That Met QC Criteria
March 17, 2011
First Posted (Estimate)
March 21, 2011
Study Record Updates
Last Update Posted (Estimate)
March 21, 2011
Last Update Submitted That Met QC Criteria
March 17, 2011
Last Verified
March 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- 0015-11-HYMC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Top-level Athletes
-
Hillel Yaffe Medical CenterWingate InstituteUnknownGenetic Polymorphism Connected to Top-level SwimmersIsrael
-
University of Nove de JulhoMulti Radiance Medical; São José Rugby ClubCompletedRecovery | Performance | High-level Rugby AthletesBrazil
-
Assistance Publique - Hôpitaux de ParisINSERM U1153CompletedTermination of Pregnancy (TOP)France
-
Shanghai First Maternity and Infant HospitalUnknown
-
Guy's and St Thomas' NHS Foundation TrustUnknownRopivacaine | Labour | Epidural Top-up | Caesarian SectionUnited Kingdom
-
PepsiCo Global R&DCompletedFluid Intake in Athletes | Sweating Rate in Athletes | Sweat Chloride Concentration in AthletesUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedPregnant Women Undergoing TOP | TOP - Failed Attempted Termination of PregnancyFrance
-
University of BrasiliaNot yet recruiting
-
Universiti Putra MalaysiaNot yet recruiting
Clinical Trials on Blood sample
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Medical University of WarsawCompletedArthroplasty | Platelet Aggregation | Methylmethacrylate EmbolismPoland
-
First Affiliated Hospital of Zhejiang UniversityRecruitingComplication | Hematologic Malignancy | Hematopoietic Stem Cell Transplantation | Chronic Graft-versus-host-diseaseChina
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceRecruitingImmune Thrombocytopenia | Autoimmune Hemolytic Anemia | Autoimmune NeutropeniaFrance
-
University Hospital, ToursCompletedMetastatic Prostate Cancer | Circulating Tumor DNAFrance
-
University Hospital, BordeauxActive, not recruitingSystemic Lupus Erythematosus | Systemic SclerodermaFrance
-
University Hospital, BordeauxCompletedRenal Function Disorder | Chronic Renal Diseases
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingNarcolepsy Type 1 | Bacterial TranslocationFrance
-
The First Affiliated Hospital of Soochow UniversityRecruitingGraft Vs Host DiseaseChina
-
Meir Medical CenterCompleted